drugset / Trial / NCT03742518
A Study Evaluating the Efficacy and Safety of SM04554 Topical Solution in Male Subjects With Androgenetic Alopecia
RandomizedParallel-groupTriple-blindTreatment
Summary
This multi-center, randomized, double-blind, placebo-controlled study, conducted in Turkey, will assess the efficacy and safety of topical SM04554 solution (0.15% and 0.25%) applied daily to the scalp of male androgenetic alopecia (AGA) subjects.
Timeline
- Start
- 2018-11-01
- Primary completion
- 2020-12-31
- Completion
- 2020-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | DALOSIRVAT | Small molecule | 0.15 % | Topical |
| Subject | DALOSIRVAT | Small molecule | 0.25 % | Topical |